Mr. Richard Delacruz, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 19233 Index St Unit 3, Porter Ranch, CA 91326 Phone: 818-357-5517 |
Alicia Alcantara, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 18942 Granada Cir, Porter Ranch, CA 91326 Phone: 818-825-0247 |
Mr. David Chong Hyun Lee, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 18880 Brasilia Dr, Porter Ranch, CA 91326 Phone: 808-224-0083 |
Ana Alvarado-leavitt, RN Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 18914 Olympia St, Porter Ranch, CA 91326 Phone: 818-515-2644 |
Emily Jordano I, RN Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 10527 Yolanda Ave, Porter Ranch, CA 91326 Phone: 952-240-5650 |
Christine Partamian, AGNP-C Registered Nurse - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 20835 Sorrento Ln, Porter Ranch, CA 91326 Phone: 818-585-1838 |
Katlyn Arrivillaga, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 20220 Sorrento Ln Apt 311, Porter Ranch, CA 91326 Phone: 260-385-5954 |
News Archive
Within the next 20 years it is expected the number of people with Alzheimer's disease (AD) will double from its current figure of half a million to one million. A new study has looked at whether certain types of drugs used to treat high blood pressure, also called hypertension, might have beneficial effects in reducing the number of new cases of Alzheimer's disease each year.
Today, OncoTartis, Inc. and Children's Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis' clinical drug candidate OT-82.
In an effort to help medical professionals, policy-makers, researchers, the news media and the general public evaluate the quality and usefulness of obesity research, a group of international obesity experts has formed a team that will review and evaluate published research papers in the field of obesity.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and serious viral infections, today announced financial results for the third quarter of fiscal year (FY) 2010 ended January 31, 2010. The company also provided an update on its clinical programs and corporate developments.
White men who exercise at high levels are 86 percent more likely than people who exercise at low levels to experience a buildup of plaque in the heart arteries by middle age, a new study suggests.
› Verified 9 days ago